Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Cancer Science, 10/23/09
Ozasa H et al. – The alteration of molecular pharmacological factors in relation with pemetrexed resistance is dose–dependent, and that up–regulation of the expression of the TS gene may have an important role in the acquired resistance to pemetrexed. In addition, TS may be a predictive marker for pemetrexed sensitivity in lung cancer.
Related Articles
Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: The FOCUS Trial
Journal of Clinical Oncology, 10/30/09
Relevance Score: 64%
Relationship of polymorphism of the tandem repeat sequence in the thymidylate synthase gene and the survival of stage III colorectal cancer patients receiving adjuvant 5-flurouracil-based chemotherapy
Journal of Surgical Oncology, 10/05/09
Relevance Score: 64%
Inducible and endothelial nitric oxide synthase expression in human atherogenesis: an immunohistochemical and ultrastructural study
Cardiovascular Pathology, 11/06/09
Relevance Score: 42%
Effect of Genetic Variation in the Human Fatty Acid Synthase Gene (FASN) on Obesity and Fat Depot-Specific mRNA Expression
Obesity, 11/10/09
Relevance Score: 41%
Dysregulation of Glycogen Synthase COOH- and NH2-Terminal Phosphorylation by Insulin in Obesity and Type 2 Diabetes Mellitus
Journal of Clinical Endocrinology and Metabolism, 10/29/09
Relevance Score: 41%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Valproic acid restores ERalpha and antiestrogen sensitivity to ERalpha-negative breast cancer cells
Molecular and Cellular Endocrinology, 11/25/09
N2 Disease in Patients With Head and Neck Squamous Cell Cancer Treated With Chemoradiotherapy
Archives of Otolaryngology, 11/25/09
Salvage treatment with upfront melphalan 100 mg/m2 and consolidation with novel drugs for fulminant progression of multiple myeloma
Annals of Hematology, 11/24/09
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk Factors Associated with Methicillin Resistance among Staphylococcus aureus Infections in Veterans
Infection Control and Hospital Epidemiology, 11/25/09
Antiretroviral Drug-Resistant Mutations at Baseline and at Time of Failure of Antiretroviral Therapy in HIV Type 1-Coinfected TB Patients
AIDS Research and Human Retroviruses, 11/24/09
Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


